RITSUKO KOMAKI to Granulocyte Colony-Stimulating Factor
This is a "connection" page, showing publications RITSUKO KOMAKI has written about Granulocyte Colony-Stimulating Factor.
Connection Strength
0.011
-
Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer. Clin Lung Cancer. 2003 Jul; 5(1):40-5.
Score: 0.011
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.